Status regarding Novo Nordisk's holding of its own shares (30 June 2016)
Bagsværd, Denmark, 1 July 2016 - In continuation of the company's announcements dated 3 February 2016 and 29 April 2016 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 June 2016 owned 18,377,645 of its own B shares of DKK 0.20, corresponding to a total nominal value of DKK 3,675,529 or 0.7% of the total share capital.
In the second quarter of 2016 a total of 9,932,000 B shares were repurchased, and 227,000 B shares were disposed to employees in connection with employee incentive programmes.
Further information
| Media: | ||
| Katrine Sperling | +45 3079 6718 | krsp@novonordisk.com |
| Ken Inchausti (US) | +1 609 786 8316 | kiau@novonordisk.com |
| Investors: |
||
| Peter Hugreffe Ankersen | +45 3075 9085 | phak@novonordisk.com |
| Melanie Raouzeos | +45 3075 3479 | mrz@novonordisk.com |
| Kasper Veje (US) | +1 609 235 8567 | kpvj@novonordisk.com |
Company announcement No 49 / 2016
Company Announcement No 49/2016
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire
HUG#2024748
\Hugin